Summary & Overview
HCPCS G8587: No Anti-Lipid Treatment at Discharge
HCPCS Level II code G8587 denotes documentation that a patient was discharged without initiation of anti-lipid (lipid-lowering) treatment. Nationally, this code matters for quality measurement and discharge medication reconciliation, as it captures instances where clinicians explicitly record the absence of lipid-lowering therapy at transition of care. Use of G8587 can affect quality reporting and comparable metrics related to cardiovascular risk management and secondary prevention.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will gain a clear understanding of what G8587 represents clinically and operationally, how it fits into discharge workflows, and which payers commonly recognize such documentation for reporting and quality measures. The publication provides benchmarks where available, summarizes relevant policy considerations, and outlines the clinical context for using the code — for example, situations involving contraindications, patient refusal, or alternative management plans.
This summary is intended for national audiences including clinicians, coding professionals, and payers seeking concise guidance on the code's purpose, reporting implications, and role in discharge medication reconciliation.
Billing Code Overview
HCPCS Level II code G8587 reports no anti-lipid treatment at discharge. This code documents that a patient was discharged without a prescription or initiation of lipid-lowering therapy following the related encounter.
-
Service type: Medication management / discharge medication decision
-
Typical site of service: Hospital inpatient or observation discharge, or any setting where discharge medication reconciliation occurs
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult hospitalized for an acute coronary syndrome (for example, ST-elevation myocardial infarction) or after an ischemic stroke who, at discharge planning, is documented as not receiving any anti-lipid therapy. The clinical workflow begins with inpatient cardiovascular or neurology teams evaluating lipid-lowering needs during the hospitalization. Discharge medication reconciliation is performed by the prescribing clinician and a pharmacist; if an anti-lipid medication (such as a statin, ezetimibe, or PCSK9 inhibitor) is intentionally not prescribed, the discharge summary documents the clinical rationale (e.g., prior severe adverse reaction, patient refusal, limited life expectancy, or other contraindication). Coding staff abstract the discharge medication list and apply billing code G8587 to indicate no anti-lipid treatment at discharge for quality reporting and performance measure scenarios. Typical site of service is inpatient acute care hospital or observation unit during discharge processing. Typical patient examples include: an elderly patient with end-stage illness where clinicians opt for comfort-focused care without initiating lipid-lowering therapy; a patient with documented prior statin-induced severe myopathy who is discharged without alternative anti-lipid agents; or a patient who refuses pharmacologic lipid therapy despite counseling.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
24 | Unrelated evaluation and management service by the same physician during a postoperative period |